BioVie
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, BioVie sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
BioVie: 6 sponsored US clinical trials, 2 recruiting.
BioVie sponsors 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Parkinsons Disease (PD), with 1 trials.
Upper-quartile sponsor footprint
BioVie sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
NE3107 in Adults With Neurological Symptoms of Long COVID
NCT06847191
A Study of NE3107 in Early Parkinson's
NCT06757010
NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa
NCT05083260
A Phase 3 Study of NE3107 in Probable Alzheimer's Disease
NCT04669028
A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites
NCT04112199
Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites
NCT03107091
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
| Phase 3 | 1 |
Therapeutic Areas
What is open in the BioVie pipeline
2 recruiting of 6 indexed (33% open); 3 completed (50%).
Phase mix: 1 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Parkinsons Disease (PD) (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
BioVie: open-pipeline peers nationwide
Peers matched on 6 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
BioVie sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this BioVie page
6 registered trials is a research-attention snapshot, not an endorsement of BioVie or any single study.
- 2 of BioVie's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Parkinsons Disease (PD) is the condition BioVie studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinsons Disease (PD) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
BioVie pipeline card: 6 registered trials from official public datasets.Report a data error.